Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ PAF49 Monoclonal Antibody (GT635)
Mouse Monoclonal Antibody
Supplier: Invitrogen™ MA517287
Description
Recommended positive controls: 293T, A431, HeLa, HepG2, A375, A549, H1299, HCT116. Store product as a concentrated solution. Centrifuge briefly prior to opening the vial.
DNA-dependent RNA polymerase catalyzes the transcription of DNA into RNA using the four ribonucleoside triphosphates as substrates. Component of RNA polymerase I which synthesizes ribosomal RNA precursors. Isoform 1 is involved in UBTF-activated transcription, presumably at a step following PIC formation.; Isoform 2 has been described as a component of preformed T-cell receptor (TCR) complex. [UniProt].
Specifications
PAF49 | |
Monoclonal | |
1 mg/mL | |
PBS with no preservative | |
O15446 | |
Cd3eap | |
Recombinant fragment contains a sequence corresponding to a region within amino acids 1 and 268 of PAF49. | |
100 μL | |
Primary | |
Human | |
Antibody | |
IgG2a |
Western Blot, Immunocytochemistry | |
GT635 | |
Unconjugated | |
Cd3eap | |
1190028F09; 2610103M17Rik; A34.5; antis; Anti-sense to ERCC-1 protein; antisense to ERCC-1 protein; Ase1; ASE-1; CAST; CD3 epsilon associated protein; antisense to Ercc1; CD3E antigen, epsilon polypeptide associated protein; CD3E antigen, epsilon polypeptide-associated protein; CD3e molecule associated protein; CD3e molecule, epsilon associated protein; Cd3eap; CD3E-associated protein; CD3-epsilon-associated protein; DNA-directed RNA polymerase I subunit RPA34; PAF49; RGD1305916; RNA polymerase I-associated factor PAF49 | |
Mouse | |
Protein G | |
RUO | |
10849 | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Liquid |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction